Guru Ownership Trend
Guru Analysis for Royalty Pharma plc (RPRX)
Royalty Pharma plc (RPRX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 8 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $617.34 M.
Top institutional holders include Cliff Asness and Pat Dorsey.
Notably, Pat Dorsey has expressed high conviction in this stock, allocating 8.82% of their equity portfolio to it.
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $91.26 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 144.8%. Conversely, Steven Cohen reduced exposure by 78.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Royalty Pharma plc (RPRX)
Major holders include Cliff Asness ($241.4 M), Pat Dorsey ($137.74 M), Renaissance Technologies (RenTech) ($108.54 M). According to the latest reported data, 8 tracked investment managers collectively hold approximately 10 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $91.26 M, with 5 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited RPRX. The total reported sell value was $24.92 M.
Yes, 1 managers opened new positions in RPRX, and 4 increased their existing holdings. The total reported buy value was $116.17 M.
